It is well documented that p38 MAPK leads to phosphorylation of p53, resulting in apoptosis induction in models of DNA damage, such as non-alcoholic fatty liver disease (NAFLD), steatohepatitis (NASH), and fibrosis [38,39]. This evidence concerns the gene TP53 and metabolic dysfunction-associated steatotic liver disease.